This report discusses US over-the-counter (OTC) pharmaceuticals (at the manufacturers' level) for the years 2005 and 2010, with forecasts for 2015. Topics covered include pharmaceutical market size, regulatory and patent status segmentation, product segmentation, retail distribution and product development, regulatory considerations, market environment, regulatory and patent status forecasts, product forecasts, industry composition and leading participants. Product segments cover nutritional, respiratory, central nervous system (CNS), dermatological, gastrointestinal, and other agents. Pharmaceutical demand by regulatory status (ethical and OTC) and commercial status (proprietary and generic) is also included. This 22 page report also includes a highlights summary and a resources section.